Pasternak Andy's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Jan 6, 2022
- Accession no.
- 0001209191-22-002297
- Filed
- Jan 6, 2022
- Trade date
- Jan 4-6, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 5 derivative transactions. Open-market sales total $795.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pasternak AndyCIK 0001792746 | Officer (EVP and Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Ordinary Shares | MOption exerciseAcquired | +48,839 | – | – | 70,669 | Direct | |
| Jan 5, 2022 | Ordinary Shares | FTax withholdingDisposed | −21,710 | $101.84 | −$2,210,946.4 | 48,959 | Direct | |
| Jan 6, 2022 | Ordinary Shares | SSaleDisposed | −500 | $97.30 | −$48,650 | 48,459 | Direct | |
| Jan 6, 2022 | Ordinary Shares | SSaleDisposed | −700 | $98.33 | −$68,831 | 47,759 | Direct | |
| Jan 6, 2022 | Ordinary Shares | SSaleDisposed | −6,438 | $99.85 | −$642,834.3 | 41,321 | Direct | |
| Jan 6, 2022 | Ordinary Shares | SSaleDisposed | −349 | $100.23 | −$34,980.27 | 40,972 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Ordinary Shares | AGrant or awardAcquired | +23,805 | $0.00 | $0 | 23,805 | Direct | |
| Jan 5, 2022 | Ordinary Shares | MOption exerciseDisposed | −14,514 | $0.00 | $0 | 14,514 | Direct | |
| Jan 5, 2022 | Ordinary Shares | MOption exerciseDisposed | −11,642 | $0.00 | $0 | 23,286 | Direct | |
| Jan 5, 2022 | Ordinary Shares | MOption exerciseDisposed | −11,067 | $0.00 | $0 | 11,069 | Direct | |
| Jan 5, 2022 | Ordinary Shares | MOption exerciseDisposed | −11,616 | $0.00 | $0 | 5,800 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.